Blockade Medical, LLC

Blockade Medical, LLC specializes in developing innovative medical devices aimed at treating neurovascular and peripheral vascular conditions, enhancing patient outcomes through cutting-edge technology. Founded in 2011 in Irvine, US, Blockade Medical, LLC focuses on the development of advanced medical devices. The company was acquired in September 2016 by Balt Extrusion SAS, a portfolio company of Bridgepoint, facilitating its expansion into key global markets. The founder's history and previous company affiliations are not publicly detailed.

Blockade Medical offers a range of medical devices targeting neurovascular and peripheral vascular conditions, including ischemic and hemorrhagic strokes. Their product portfolio features the Long Sheath Revascularization Device, Venous Remodelling Balloon, and Self-Expandable Braided Stents, designed for clinical use in hospitals and healthcare institutions across North America, Europe, and select regions in Asia. The company generates revenue through direct sales to healthcare providers, including hospitals and specialized clinics. Its sales structure leverages flagship products, with transactions accommodating bulk purchases and contracts for ongoing supply, ensuring consistent availability of advanced medical solutions to meet clinical needs.

Following the acquisition by Balt Extrusion SAS, Blockade Medical plans to enhance its footprint in the U. S. and expand its presence in key global markets. The recent funding of USD 2.

37 mn will support these initiatives, although specific upcoming products or release dates are not disclosed. The acquisition is anticipated to facilitate broader market access and growth opportunities.